OptiGene

The device, available for license from the Lawrence Livermore National Laboratories Industrial Partnerships Office, integrates a single-tube nucleic acid extraction method with loop-mediated isothermal amplification or reverse transcriptase LAMP.

OptiGene has licensed Eiken's loop-mediated isothermal amplification method to use in nucleic acid amplification reagents for infectious disease testing; while the UK's VLA has licensed the technology for veterinary testing and environmental monitoring.

OptiGene will develop, manufacture, and sell nucleic acid amplification reagents for research use, and VLA will develop, manufacture, and provide testing for nucleic acid diagnostics for veterinary purposes and environmental monitoring.

The platform will be based on isothermal amplification and its developers aim to cut the amount of time it takes to diagnose STDs to 15 minutes or less at the point of care.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.